Persistent inflammation worsens short-term outcomes in massive stroke patients

BMC Neurology

Table 3 Comparisons of short-term outcomes between patients with and without persistent inflammation

Short-term outcomes	Persistent inflammation		p value	RR	95%CI
Short-term outcomes	With	Without	p value	RR	95%CI
Pulmonary infection	21 (77.8)	23 (46)	0.009^*	1.7	1.2–2.4
Urinary tract infection	3 (11.1)	6 (12)	1	–	–
1-month mortality	8 (30)	2 (4)	0.003^*	7.7	1.8–33.6
1-month mRS	5 (4–6)^a	3 (2–4)^a	0.0005^*	–	–
3-month mRS	3 (2–6) ^a	2 (1–3) ^a	0.139	–	–

Abbreviations: mRS modified Rankin scale; RR elative risk; CI confidence interval
Unless specified, values are p values in non-parametric tests and values are numbers of patients (%)
^aMedian (interquartile range)
^*Statistically significant

ISSN: 1471-2377